A detailed history of Schonfeld Strategic Advisors LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 38,245 shares of VRTX stock, worth $19.8 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
38,245
Previous 21,614 76.95%
Holding current value
$19.8 Million
Previous $9.03 Million 98.43%
% of portfolio
0.12%
Previous 0.06%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$392.81 - $485.53 $6.53 Million - $8.07 Million
16,631 Added 76.95%
38,245 $17.9 Million
Q1 2024

May 15, 2024

BUY
$407.69 - $446.08 $8.81 Million - $9.64 Million
21,614 New
21,614 $9.03 Million
Q3 2023

Nov 14, 2023

SELL
$338.18 - $362.46 $9.08 Million - $9.73 Million
-26,848 Reduced 39.12%
41,775 $14.5 Million
Q2 2023

Aug 14, 2023

SELL
$314.42 - $351.91 $1.17 Million - $1.31 Million
-3,710 Reduced 5.13%
68,623 $24.1 Million
Q1 2023

May 15, 2023

BUY
$283.23 - $323.1 $18.4 Million - $21 Million
65,133 Added 904.63%
72,333 $22.8 Million
Q4 2022

Feb 14, 2023

SELL
$285.76 - $321.48 $2.33 Million - $2.62 Million
-8,143 Reduced 53.07%
7,200 $2.08 Million
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $4.2 Million - $4.69 Million
15,343 New
15,343 $4.44 Million
Q1 2022

May 16, 2022

SELL
$221.42 - $260.97 $2.02 Million - $2.38 Million
-9,132 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$177.01 - $223.45 $3.8 Million - $4.8 Million
-21,465 Reduced 70.15%
9,132 $2.01 Million
Q3 2021

Nov 16, 2021

BUY
$181.39 - $202.99 $2.83 Million - $3.17 Million
15,597 Added 103.98%
30,597 $5.55 Million
Q2 2021

Aug 16, 2021

SELL
$187.49 - $221.1 $4.19 Million - $4.94 Million
-22,348 Reduced 59.84%
15,000 $3.02 Million
Q1 2021

May 17, 2021

BUY
$207.02 - $241.31 $3.02 Million - $3.52 Million
14,584 Added 64.07%
37,348 $8.03 Million
Q4 2020

Feb 16, 2021

BUY
$207.01 - $276.09 $3.51 Million - $4.68 Million
16,937 Added 290.66%
22,764 $5.38 Million
Q3 2020

Nov 16, 2020

BUY
$255.65 - $303.1 $296,554 - $351,596
1,160 Added 24.86%
5,827 $2,000
Q2 2020

Aug 14, 2020

BUY
$225.48 - $295.8 $229,313 - $300,828
1,017 Added 27.86%
4,667 $1.36 Million
Q1 2020

May 15, 2020

SELL
$199.77 - $247.81 $913,348 - $1.13 Million
-4,572 Reduced 55.61%
3,650 $869,000
Q4 2019

Feb 14, 2020

SELL
$166.71 - $223.91 $3.98 Million - $5.35 Million
-23,878 Reduced 74.39%
8,222 $1.8 Million
Q3 2019

Nov 14, 2019

BUY
$166.23 - $187.09 $2.58 Million - $2.9 Million
15,500 Added 93.37%
32,100 $5.44 Million
Q2 2019

Aug 14, 2019

SELL
$164.61 - $190.37 $460,908 - $533,036
-2,800 Reduced 14.43%
16,600 $3.04 Million
Q1 2019

May 15, 2019

SELL
$163.73 - $194.7 $4.42 Million - $5.26 Million
-26,991 Reduced 58.18%
19,400 $3.57 Million
Q4 2018

Feb 14, 2019

BUY
$151.91 - $192.21 $3.43 Million - $4.34 Million
22,591 Added 94.92%
46,391 $7.69 Million
Q3 2018

Nov 14, 2018

BUY
$167.73 - $192.74 $3.99 Million - $4.59 Million
23,800 New
23,800 $4.59 Million
Q2 2018

Aug 14, 2018

SELL
$145.72 - $169.96 $948,200 - $1.11 Million
-6,507 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$151.6 - $177.13 $283,340 - $331,055
1,869 Added 40.3%
6,507 $1.06 Million
Q4 2017

Feb 14, 2018

SELL
$137.28 - $155.55 $4.21 Million - $4.76 Million
-30,632 Reduced 86.85%
4,638 $695,000
Q3 2017

Nov 14, 2017

BUY
$148.13 - $162.24 $5.22 Million - $5.72 Million
35,270
35,270 $5.36 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $133B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.